Leverage has improved markedly, with debt-to-equity declining to 0.42 from 1.05 in 2024Q1, as total debt fell to $1.6B and equity surged to $3.7B, though the low reported D/E may understate true leverage from operating leases.
American Healthcare REIT, Inc. (AHR) balance sheet — 10-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 |
|---|
| Total Assets | 5.7B | 5.43B | 4.49B | 4.58B | 4.79B | 4.58B | 3.23B | 3.17B | 2.89B | 2.8B | 2.79B |
| Asset Growth % | 74.88% | 20.9% | -1.96% | -4.36% | 4.51% | 41.59% | 1.97% | 9.8% | 3.16% | 0.21% | - |
| Real Estate & Other Assets | 439.5M | -4.28B | 3.47B | 3.53B | 26.36M | 23.06M | 21.68M | 22.79M | 24.51M | 23.2M | 26.66M |
| PP&E (Net) | 4.54B | 271M | 163.99M | 227.85M | 3.86B | 3.67B | 2.53B | 2.49B | 2.22B | 2.16B | 2.14B |
| Investment Securities | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Total Current Assets | 156.9M | 319.15M | 354.89M | 297.1M | 341.92M | 330.74M | 356.95M | 331.44M | 303.29M | 275.51M | 269.55M |
| Cash & Equivalents | 156.9M | 114.84M | 76.7M | 43.45M | 65.05M | 81.6M | 113.21M | 53.15M | 35.13M | 33.66M | 29.12M |
| Receivables | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 47.61M | 48.8M | 72.72M | 66.37M | 55.6M | 77.08M | 100.75M | 87.89M | 83.67M |
| Intangible Assets | 237.24M | 253.24M | 161.47M | 180.47M | 236.28M | 248.87M | 154.69M | 160.25M | 179.52M | 180.31M | 200.83M |
| Total Liabilities | 1.96B | 2.07B | 2.18B | 3.12B | 3.14B | 2.75B | 2.16B | 2.07B | 1.63B | 1.42B | 1.34B |
| Total Debt | 1.57B | 1.69B | 1.87B | 3.02B | 2.83B | 2.5B | 1.88B | 1.85B | 1.45B | 1.25B | 1.19B |
| Net Debt | 1.41B | 1.57B | 1.79B | 2.98B | 2.77B | 2.42B | 1.76B | 1.79B | 1.42B | 1.22B | 1.16B |
| Long-Term Debt | 892.68M | 1B | 1.02B | 1.34B | 2.24B | 1.43B | 1.68B | 1.64B | 1.45B | 1.24B | 1.15B |
| Short-Term Borrowings | 549.87M | 549.76M | 688.53M | 1.22B | 316.73M | 921.9M | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 462.87M | 135.6M | 165.24M | 451M | 273.07M | 145.49M | 193.63M | 207.37M | 4.7M | 16.19M | 45.3M |
| Total Current Liabilities | 882.02M | 867.5M | 946.86M | 1.47B | 560.57M | 1.11B | 194.68M | 173.72M | 144.79M | 126.56M | 107.33M |
| Accounts Payable | 0 | 317.74M | 258.32M | 242.91M | 83.69M | 64.41M | 67.83M | 62.2M | 43.03M | 43.97M | 37.18M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 62.47M | 61.68M | 54.86M | 82.23M | 60.38M | 60.78M | 89.27M | 48.77M | 38.47M | 41.03M | 46.8M |
| Total Equity | 3.74B | 3.36B | 2.3B | 1.46B | 1.65B | 1.83B | 1.07B | 1.1B | 1.26B | 1.38B | 1.45B |
| Equity Growth % | 171.09% | 45.85% | 57.91% | -11.53% | -9.85% | 70.22% | -2.53% | -12.26% | -8.86% | -4.9% | - |
| Shareholders Equity | 3.69B | 3.32B | 2.26B | 1.27B | 1.4B | 1.58B | 866.11M | 900.55M | 1.06B | 1.19B | 1.26B |
| Minority Interest | 47.34M | 39.98M | 42.93M | 188.86M | 249.27M | 248.28M | 208.72M | 202.21M | 196.37M | 191.16M | 187.27M |
| Common Stock | 1.94M | 1.85M | 1.56M | 661K | 661K | 658K | 1.8M | 1.94M | 1.98M | 1.99M | 1.96M |
| Additional Paid-in Capital | 5.3B | 4.88B | 3.72B | 2.55B | 2.54B | 2.53B | 1.73B | 1.73B | 1.77B | 1.79B | 1.75B |
| Retained Earnings | -1.6B | -1.56B | -1.46B | -1.28B | -1.14B | -951.3M | -864.27M | -827.55M | -704.75M | -598.04M | -490.3M |
| Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on Assets (ROA) | 2.25% | 1.41% | -0.83% | -1.53% | -1.74% | -1.22% | 0.07% | -0.16% | 0.47% | 0.4% | -5.23% |
| Return on Equity (ROE) | 3.63% | 2.46% | -2.01% | -4.6% | -4.67% | -3.29% | 0.2% | -0.42% | 1.01% | 0.79% | -10.07% |
| Debt / Assets | 27.48% | 31.07% | 41.68% | 65.95% | 59.19% | 54.62% | 58% | 58.22% | 50.27% | 44.77% | 42.6% |
| Debt / Equity | 0.42x | 0.50x | 0.81x | 2.07x | 1.72x | 1.37x | 1.75x | 1.67x | 1.16x | 0.91x | 0.82x |
| Net Debt / EBITDA | 3.21x | 3.99x | 5.01x | 9.48x | 9.51x | 8.27x | 6.68x | 5.44x | 5.15x | 4.16x | 2.74x |
| Book Value per Share | 19.62 | 20.14 | 17.64 | 22.09 | 24.91 | 27.63 | 16.27 | 24.25 | 25.14 | 27.83 | 29.87 |
Quick answers to the most common questions about buying AHR stock.
As of 2025, American Healthcare REIT, Inc. (AHR) had total assets of $5.43B including $319.1M in current assets.
American Healthcare REIT, Inc. (AHR) carries total debt of $1.69B. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
American Healthcare REIT, Inc. (AHR) has total shareholders' equity (book value) of $3.32B ($20.14 book value per share). Book value represents the net worth of the company belonging to common stock holders.
American Healthcare REIT, Inc. (AHR) reported a current ratio of 0.37x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Labor cost pressure on margins
Metrics are mathematically derived from official filings.
Balance Sheet Expansion on Senior Housing
Total assets grew 24% YoY to $5.7B in 2026Q2, driven by acquisitions and internal growth, while debt-to-equity fell to 0.42, per the latest quarterly report.
The balance sheet is expanding rapidly, with total assets increasing from $4.6B in 2024Q2 to $5.7B in 2026Q2, a 24% compound annual growth rate. This growth is funded by a mix of equity issuance and modest debt, as total debt rose only 7% over the same period, while equity more than doubled. The resulting leverage reduction, with D/E down from 1.06 to 0.42, suggests a deliberate deleveraging strategy that strengthens the balance sheet for future opportunities.
Portfolio Quality Anchored by Integrated Campuses
Property, plant, and equipment of $4.5B represents 79% of total assets, reflecting a heavy investment in integrated senior health campuses, as reported in the balance sheet.
The portfolio is dominated by real estate assets, with PPE net of $4.5B in 2026Q2, up from $3.7B in 2024Q1, indicating significant capital deployment into properties. The focus on integrated senior health campuses, which combine skilled nursing, assisted living, and independent living, likely enhances occupancy stability and resident retention, though it also exposes the company to operational risks. The geographic diversification across 36 U.S. states and the UK provides some mitigation, but the concentration in healthcare real estate remains a key characteristic.
Leverage Declines as Debt Matures
Total debt decreased to $1.6B in 2026Q2 from $2.2B in 2024Q1, while cash increased to $156.9M, improving the debt-to-equity ratio to 0.42, based on the latest balance sheet.
The company has been actively reducing its debt burden, with total debt down 27% from its peak in 2024Q1. This deleveraging, combined with a rise in cash reserves, has improved the debt-to-equity ratio from 1.05 to 0.42, indicating a stronger balance sheet. However, the maturity ladder and interest rate exposure are not fully disclosed, and the low D/E may partly reflect the consolidation of operating entities, so investors should monitor the mix of secured versus unsecured debt and any floating-rate exposure.
Equity Base Strengthens via Retained Earnings
Equity surged to $3.7B in 2026Q2 from $2.0B in 2024Q1, a 85% increase, driven by retained earnings and capital raises, as shown in the balance sheet data.
The equity base has expanded significantly, supported by positive FFO and retained earnings, as well as likely secondary offerings. This equity growth has been instrumental in funding acquisitions and reducing leverage, but it also implies dilution for existing shareholders. The low ROE of 0.8% in 2026Q2 suggests that the capital deployed has not yet generated outsized returns, which may be a concern if the trend persists.
Liquidity Position Improves with Cash Build
Cash and equivalents rose to $156.9M in 2026Q2 from $77.0M in 2024Q1, while FFO coverage of interest appears adequate, per the latest financial statements.
The liquidity position has strengthened, with cash more than doubling over the period, providing a buffer for operational needs and potential acquisitions. The fixed charge coverage ratio, though not directly provided, appears healthy given the low debt levels and positive FFO. However, the negative NOI in 2026Q2 and volatile FFO warrant monitoring, as they could impact liquidity if sustained.
Lease Expirations and Pipeline Pose Risks
With a significant portion of revenue from SHOP and integrated campuses, lease expirations are less relevant, but development pipeline funding needs could strain liquidity, as per the balance sheet.
The forward visibility is tied to occupancy and reimbursement rates rather than lease expirations, given the operating nature of the senior housing segments. The development pipeline, while not detailed, may require significant capital, and the company's ability to fund it internally will depend on FFO growth. The recent earnings beat and raised guidance suggest improving momentum, but the thin margins and labor cost pressures could limit cash flow generation.
Hidden Leverage in Operating Leases
The low reported D/E of 0.42 may understate true leverage if operating leases for properties are not capitalized, as suggested by the balance sheet data.
AHR's reported debt-to-equity ratio is remarkably low for a healthcare REIT, but this may be misleading if the company uses operating leases for some properties, which would not appear on the balance sheet. Additionally, the consolidation of Trilogy Health Services involves non-controlling interests that could represent off-balance-sheet obligations. Investors should scrutinize the footnotes for lease commitments and joint venture debt to assess the true leverage profile.